Miller Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Miller Capital Partners's BMY Position: Q2 2026 in Review
Miller Capital Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,435 shares worth $82.7K. The position accounts for 0.03% of the portfolio, ranked #147.
Miller Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $87K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Miller Capital Partners held 1,435 shares of Bristol-Myers Squibb worth $82.7K as of Q2 2026.
- Miller Capital Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.03% of Miller Capital Partners's portfolio in Q2 2026, its #147 holding.
- Miller Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Miller Capital Partners's Bristol-Myers Squibb position peaked at $87K in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Miller Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.